<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 10_9-10_201</article-id>
<article-id pub-id-type="doi">10.15836/ccar.2015.201</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Is there a difference in release of high sensitive troponin I and brain natriuretic peptide in acute heart failure with reduced and preserved ejection fraction?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5175-8941</contrib-id><name><surname>Durak-Nalbantic</surname><given-names>Azra</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7977-9819</contrib-id><name><surname>Serdarevic</surname><given-names>Nafija</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5374-0892</contrib-id><name><surname>Begic</surname><given-names>Alden</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7309-1455</contrib-id><name><surname>Dilic</surname><given-names>Mirza</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4864-2013</contrib-id><name><surname>Kulic</surname><given-names>Mehmed</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9948-99717</contrib-id><name><surname>Hasanefendic</surname><given-names>Berina</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1198-540X</contrib-id><name><surname>Dzubur</surname><given-names>Alen</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4967-7616</contrib-id><name><surname>Hamzic-Mehmedba&#x0161;ic</surname><given-names>Aida</given-names></name></contrib>
<aff id="aff1">University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address for correspondence: Azra Durak-Nalbantic, Klinicki univerzitetski centar Sarajevo, Bolnicka 25, &#x2028;71000 Sarajevo, Bosnia and Herzegovina. / Phone: +387-61221199 / E-mail: <email xlink:href="azradurak@yahoo.com">azradurak@yahoo.com</email></corresp></author-notes>
<pub-date pub-type="ppub"><month>10</month><year>2015</year></pub-date>
<volume>10</volume>
<issue>9-10</issue>
<fpage>201</fpage>
<lpage>201</lpage>
<history>
<date date-type="received"><day>10</day><month>09</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>09</month><year>2015</year></date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>brain natriuretic peptide</kwd><kwd>troponin</kwd><kwd>acute heart failure</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Introduction: Recently, it has been recognised that up to 50% of patients with heart failure have preserved ejection fraction. High sensitive troponin I (hs TnI) and brain natriuretic peptide (BNP) are elevated in acute heart failure (AHF). (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>-<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) The aim of this study was to investigate possible differences in their release in subpopulation with reduced ejection fraction (HF-REF) in comparison to preserved ejection fraction (HF-PEF) subpopulation.</p>
<p>Patients and Methods: we analyzed data from 42 patients hospitalised with AHF in Intensive Care Unit, 2 patients were excluded due to intrahospital death within 72 hours from admission. hs TnI was tested at the admission, while BNP was tested at admission (BNP1) and at discharge (BNP2). We also calculated procentual reduction of BNP at discharge compared to admission values.</p>
<p>Results: 25 patients (62.5%) had HF-REF with mean LVEF 31.48 +/- 4.77%. 15 patients (37.5%) had HF-PEF with mean LVEF 52.25+/-2.35%. There was no significant difference in hs TnI release according to different systolic function- in HF-REF group mean values was 151.91 pg/ml vs 60.37 pg/ml in HF-PEF group (p=0.1). BNP1 mean values were higher in HF-REF group compared to HF-PEF group&#x2013;2183.43 pg/ml versus 853.96 pg/ml, p &lt;0.05. Discharge mean BNP values (BNP2) were also higher in HF-REF group compared to HF-PEF-890.30 pg/ml versus 358.03 pg/ml, p &lt;0.05. There was no significant difference in in-hospital procentual reduction of BNP values (admission vs discharged values) in HF-REF and HF-PEF group- 55.72% versus 55.56% (p=0.77).</p>
<p>Conclusion: Even with more impaired systolic function, hs troponin I mean values in HF-REF were not higher compared to HF-PEF group. Admission and discharge BNP levels were higher in patients with reduced EF compared to patients with preserved EF. That means that neurohormonal activation is more pronounced in subpopulation of patients with reduced LVEF. Percentage of intrahospital BNP reduction were similar in were similar in both groups..</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omland</surname><given-names>T</given-names></name><name><surname>R&#x0159;sj&#x0159;</surname><given-names>H</given-names></name><name><surname>Giannitsis</surname><given-names>E</given-names></name><name><surname>Agewall</surname><given-names>S</given-names></name></person-group>. <article-title>Troponins in heart failure.</article-title> <source>Clin Chim Acta</source>. <year>2015</year>;<volume>443</volume>:<fpage>78</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2014.08.016</pub-id><pub-id pub-id-type="pmid">25151947</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santhanakrishnan</surname><given-names>R</given-names></name><name><surname>Chong</surname><given-names>JP</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><name><surname>Ling</surname><given-names>LH</given-names></name><name><surname>Sim</surname><given-names>D</given-names></name><name><surname>Leong</surname><given-names>KT</given-names></name><etal/></person-group> <article-title>Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro BNP in HF with preserved vs. reduced ejection fraction.</article-title> <source>Eur J Heart Fail</source>. <year>2012</year>;<volume>14</volume>(<issue>12</issue>):<fpage>1338</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1093/eurjhf/hfs130</pub-id><pub-id pub-id-type="pmid">22869458</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>Linssen</surname><given-names>GC</given-names></name><name><surname>Jaarsma</surname><given-names>T</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name><name><surname>Hoes</surname><given-names>AW</given-names></name><name><surname>Tijssen</surname><given-names>JG</given-names></name><etal/></person-group> <article-title>BNP and prognosis in heart failure patients with preserved and reduced ejection fraction.</article-title> <source>J Am Coll Cardiol</source>. <year>2013</year>;<volume>61</volume>(<issue>14</issue>):<fpage>1498</fpage>&#x2013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2012.12.044</pub-id><pub-id pub-id-type="pmid">23500300</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
